FDA OKs first in vitro route to expanded approval
Nature Reviews Drug Discovery 16, 591 (2017).
doi:10.1038/nrd.2017.140
Author: Katie Kingwell
In vitro data can be used to accelerate the approval of drugs that target specific disease-causing mutations for additional subpopulations of patients with rare diseases such as cystic fibrosis.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Katie Kingwell Tags: News and Analysis Source Type: research